Posts by: Charles Moore

Charles Moore

Charles is a force to be reckoned with in the world of print and new media. From an interview with him in LowEndMac: ”His articles, features, and commentaries have appeared in more than 40 magazines, newspapers and websites in Canada, the US, the UK, and Australia. . . a columnist for The Halifax Daily News and the Saint John Telegraph Journal, Atlantic Fisherman, and news editor and columnist for Applelinks.com, a columnist and contributing editor for MacOpinion and PBCentral, as well as writing for Low End Mac.” Charles serves as the Senior Section Editor for the Science and Research section of BioNews Texas and contributes science-related articles on a daily basis.

May 18, 2015May 18, 2015

Heart Of Gold’s Camp Moss For Children With Cardio Issues Launches GoFundMe Campaign

Dallas, Texas based Heart of Gold Foundation is a non-profit organization dedicated to improving the quality of life for medically challenged and needy children who, without the organization’s help, might ... Read more

May 5, 2015May 5, 2015

Austrian Researchers Develop New Material For Creating Artificial Blood Vessels

Arteriosclerotic vascular disorders are one of the most common causes of death in industrialized countries. Blockage of blood vessels can quickly become dangerous, and in these situations a bypass operation ... Read more

April 10, 2015April 10, 2015

Houston Startup To Present Abstract Describing Intravascular Blood Pump At Conference

The research team behind Houston-based Procyrion, Inc.’s Aortix long-term circulatory support pump for chronic heart failure patients will deliver a presentation at the 2015 International Society for Heart and Lung ... Read more

April 1, 2015April 1, 2015

Study Investigates Ultrasound And tPA Used In Combination To Treat Stroke

Houston’s UT Health Medical School will be a participant institution in an international, Phase III clinical trial recently launched to study the effectiveness and safety of using ultrasound in combination with a clot-busting ... Read more

April 1, 2015April 1, 2015

FDA Approves Impella 2.5 Blood Pump For Patients Undergoing High Risk Percutaneous Coronary Intervention (PCI) Procedures

Danvers, Massachusetts based in Abiomed, Inc., specialists in heart support technologies and circulatory boosting medical devices, has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella ... Read more

March 12, 2015March 13, 2015

“Digitizing” Heart Cell Crosstalk May Help Locate Dangerous Heart Rhythm Epicenters

An international, multi-institutional research team led by Johns Hopkins Medicine Assistant Professor of Medicine and Biomedical Engineering and Assistant Professor of Medicine Hiroshi Ashikaga, M.D., Ph.D., has succeeded in developing a ... Read more

March 9, 2015March 9, 2015

FDA Flags Stroke, Heart Attack, and Death Risk Associated With Approved Testosterone Products

The U.S. Food and Drug Administration (FDA) has issued a cautionary alert regarding prescription testosterone products that the agency has approved only for men with low testosterone levels due to ... Read more

February 24, 2015February 25, 2015

Studies Show iRhythm ZIO Service Reduces Cost Of Arrhythmia Detection Compared To Standard Methods

Lincolnshire, Illinois-based iRhythm Technologies, Inc.’s ZIO service combines wearable biosensor devices with mobile and cloud-based technology designed to improve how heart arrhythmias are diagnosed and managed. A study published in ... Read more

February 17, 2015February 18, 2015

Abiomed Impella RP First FDA Approved Percutaneous Single Access Heart Pump Designed for Right Heart Support

Danvers, Massachusetts based Abiomed, Inc. has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE) for its Impella RP (Right Percutaneous) single access heart pump ... Read more

February 13, 2015February 13, 2015

“Artificial Blood Vessels” – Micro-Imprinting And Electrospinning Technology Yields Superior Synthetic Composite Vascular Graft Material

Researchers working at Shanghai University’s Rapid Manufacturing Engineering Center in China have developed what is believed to be the world’s first tri-layer vascular graft. By designing a three layer composite ... Read more